Formation Bio CEO Ben Liu on Fixing the Bottleneck Slowing Down Medicine
CEO & Founder Conversations
•
19m
Formation Bio is rewriting the rules of drug development at a time when AI is accelerating drug discovery far faster than the industry can bring new therapies to patients. CEO Ben Liu goes Inside the ICE House to explain why the real bottleneck in pharma isn't finding promising drug candidates, it's developing them efficiently and at scale. He unpacks Formation Bio's AI-native model, which acquires already-discovered drugs and deploys proprietary tools to optimize trial design, predict clinical outcomes, and identify overlooked disease indications.
Up Next in CEO & Founder Conversations
-
Geordie CEO Henry Comfort + Balderton...
Geordie CEO Henry Comfort + Balderton Capital Partner James Wise joins Kristen Scholer on NYSE Floor Talk
-
Camp Commerce: Former Jones Road CEO ...
Former Jones Road CEO Cody Plofker hoins Ashley Mastronardi on NYSE Floor Talk
-
Third Coast Bank CEO Bart Caraway on ...
Third Coast Bancshares Founder and CEO Bart Caraway joins Inside the ICE House to discuss building a Texas-based community bank from a vision into a publicly traded company now listed on the New York Stock Exchange. He reflects on launching the bank in 2008 at the onset of the Great Recession and...
